Repligen said to have rejected $14 billion takeover offer from Catalent, reports StreetInsider
Thursday, 11 August 2022, 9:17 pm
Betaville notes rivals at StreetInsider have picked up on the Repligen Corporation takeover rumour that has been doing the rounds in the last few days.
According to StreetInsider, Catalent - a US-listed biopharmaceutical company - has been circling Repligen, which makes materials used in the manufacture of biological drugs...